HealthCare Global Enterprises Ltd. 2023 AR2
The report highlights HealthCare Global Enterprises Limited's (HCG) clinical and financial progress during the fiscal year 2022-23. The company introduced advanced technologies in India, including the AI-driven Varian Ethos™ Adaptive Radiotherapy and the Illumina Nextseq 2000 Sequencing System for comprehensive genomic profiling. HCG achieved its highest-ever annual revenue from operations, growing 21% year-on-year, alongside robust EBITDA growth. On the environmental front, the company commissioned a 2.25 MW solar power plant in Karnataka to reduce its carbon footprint and transitioned to becoming a mercury-free hospital chain.
Company: HealthCare Global Enterprises Ltd.
Sector: Healthcare & social services
Country: India
Year: 2023
Type: AR2
Pages: 330
HealthCare Global Enterprises Ltd.
The report highlights HealthCare Global Enterprises Limited's (HCG) clinical and financial progress during the fiscal year 2022-23. The company introduced advanced technologies in India, including the AI-driven Varian Ethos™ Adaptive Radiotherapy and the Illumina Nextseq 2000 Sequencing System for comprehensive genomic profiling. HCG achieved its highest-ever annual revenue from operations, growing 21% year-on-year, alongside robust EBITDA growth. On the environmental front, the company commissioned a 2.25 MW solar power plant in Karnataka to reduce its carbon footprint and transitioned to becoming a mercury-free hospital chain.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 01, 2022 - Mar 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees